These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1391261)
1. Effectiveness of curosurf for severe respiratory distress syndrome: a case-control study. Valls-i-Soler A; Lizarraga M; López de Heredia J; Roman L; Hernáez E; Gastiasoro E Biol Neonate; 1992; 61 Suppl 1():21-5. PubMed ID: 1391261 [TBL] [Abstract][Full Text] [Related]
2. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome. Wiseman LR; Bryson HM Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760 [TBL] [Abstract][Full Text] [Related]
3. A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group. Robertson B; Curstedt T; Tubman R; Strayer D; Berggren P; Kok J; Koppe J; van Sonderen L; Halliday H; McClure G Eur J Pediatr; 1992 May; 151(5):372-6. PubMed ID: 1396894 [TBL] [Abstract][Full Text] [Related]
4. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials. Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793 [TBL] [Abstract][Full Text] [Related]
5. Economic impact of porcine surfactant replacement (Curosurf) for severe neonatal respiratory distress syndrome. Tubman TR; Halliday HL; Normand C J Perinat Med; 1991; 19 Suppl 1():403-7. PubMed ID: 1779394 [No Abstract] [Full Text] [Related]
6. [Effects of surfactant administration in neonates with respiratory distress syndrome. II. Radiographic changes]. Gadzinowski J; Halliday H; Szymankiewicz M; Rzymska I; Solawa M Ginekol Pol; 1992 Aug; 63(8):373-6. PubMed ID: 1304522 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of surfactant administration in neonates with respiratory distress syndrome. III. The role of intra-uterine stimulation on lung maturity]. Gadzinowski J; Halliday H; Szymankiewicz M; Breborowicz G; Sackey S; Sobczak E Ginekol Pol; 1993 Feb; 64(2):74-7. PubMed ID: 8359730 [TBL] [Abstract][Full Text] [Related]
8. Randomized multicentre trial of treatment with porcine natural surfactant for moderately severe neonatal respiratory distress syndrome. The Collaborative European Multicentre Study Group. Bevilacqua G; Halliday H; Parmigiani S; Robertson B J Perinat Med; 1993; 21(5):329-40. PubMed ID: 8126628 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of severe respiratory distress syndrome with surfactant]. Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999 [TBL] [Abstract][Full Text] [Related]
11. A multicenter, randomized, double-blind trial of a new porcine surfactant in premature infants with respiratory distress syndrome. Rebello CM; Precioso AR; Mascaretti RS; Einstein (Sao Paulo); 2014; 12(4):397-404. PubMed ID: 25628188 [TBL] [Abstract][Full Text] [Related]
12. [Neonatal respiratory distress syndrome treated with a natural surfactant. The Norwegian Curosurf study]. Saugstad OD; Danielsen K; Grønn M; Holt J; Meberg A; Silberg IE; Okland O Tidsskr Nor Laegeforen; 1993 Aug; 113(19):2389-93. PubMed ID: 8378900 [TBL] [Abstract][Full Text] [Related]
13. [Surfactant treatment of premature infants with respiratory distress syndrome]. Saugstad OD; Gloppestad K Tidsskr Nor Laegeforen; 1990 Nov; 110(29):3737-41. PubMed ID: 2274941 [TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network. Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199 [TBL] [Abstract][Full Text] [Related]
15. On "A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants" (Am J Perinatol 2004;21:109-120). Bancalari E Am J Perinatol; 2004 Jul; 21(5):307-9. PubMed ID: 15232767 [No Abstract] [Full Text] [Related]
16. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant? Kukkonen AK; Virtanen M; Järvenpää AL; Pokela ML; Ikonen S; Fellman V Acta Paediatr; 2000 May; 89(5):556-61. PubMed ID: 10852192 [TBL] [Abstract][Full Text] [Related]
17. Factors influencing morbidity and mortality in infants with severe respiratory distress syndrome treated with single or multiple doses of a natural porcine surfactant. Herting E; Speer CP; Harms K; Robertson B; Curstedt T; Halliday HL; Compagnone D; Gefeller O; McClure G; Reid M Biol Neonate; 1992; 61 Suppl 1():26-30. PubMed ID: 1391262 [TBL] [Abstract][Full Text] [Related]
18. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome. Sanghvi KP; Merchant RH Indian Pediatr; 1998 Jun; 35(6):533-6. PubMed ID: 10216648 [No Abstract] [Full Text] [Related]
19. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study]. Shinwell ES; Zmora E; Leven D; Berger I; Karplus M Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835 [TBL] [Abstract][Full Text] [Related]
20. Pulmonary functional outcome at one year of age in infants treated with natural porcine surfactant at birth. Walti H; Boulé M; Moriette G; Relier JP Biol Neonate; 1992; 61 Suppl 1():48-53. PubMed ID: 1391266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]